Electro-Optical Sciences Announces Participation at 8th Annual Needham Life Sciences Conference

IRVINGTON, NY--(Marketwire - June 5, 2009) - Electro-Optical Sciences, Inc. ("EOS") (NASDAQ: MELA), a medical technology company focused on the design and development of MelaFind®, a non-invasive, point-of-care instrument to assist in the early diagnosis of melanoma, today announced that Joseph V. Gulfo, MD, president and chief executive officer, will present at the 8th Annual Needham Life Sciences Conference taking place at the New York Palace Hotel on June 10 - 11, 2009.

Dr. Gulfo's presentation is scheduled for Wednesday, June 10 at 1:30pm ET. To access the live webcast of this presentation, visit www.eosciences.com. A replay of this presentation will be available on the company's website for thirty days following the presentation.

About Electro-Optical Sciences

Electro-Optical Sciences is a medical technology company focused on developing MelaFind®, a non-invasive and objective computer vision system intended to aid in the early detection of melanoma. EOS designed MelaFind® to assist in the evaluation of pigmented skin lesions, including atypical moles, which have one or more clinical or historical characteristics of melanoma, before a final decision to biopsy has been rendered. MelaFind® acquires and displays multi-spectral (from blue to near infrared) digital images of pigmented skin lesions and uses automatic image analysis and statistical pattern recognition to help identify lesions to be considered for biopsy to rule out melanoma.

For more information on EOS, visit www.eosciences.com.

Safe Harbor

This press release includes "forward-looking statements" within the meaning of the Securities Litigation Reform Act of 1995. These statements include but are not limited to our plans, objectives, expectations and intentions and other statements that contain words such as "expects," "contemplates," "anticipates," "plans," "intends," "believes" and variations of such words or similar expressions that predict or indicate future events or trends, or that do not relate to historical matters. These statements are based on our current beliefs or expectations and are inherently subject to significant uncertainties and changes in circumstances, many of which are beyond our control. There can be no assurance that our beliefs or expectations will be achieved. Actual results may differ materially from our beliefs or expectations due to economic, business, competitive, market and regulatory factors.

Contact Information: For further information contact: David Carey Lazar Partners Ltd. 212-867-1768